LGRNX | RGAHX | LGRNX / RGAHX | |
Total Expense Ratio | 0.57 | 0.44 | 130% |
Annual Report Gross Expense Ratio | 0.57 | 0.44 | 130% |
Fund Existence | 13 years | 10 years | - |
Gain YTD | 11.194 | 15.727 | 71% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 250 | 400,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 17.7B | 328B | 5% |
Annual Yield % from dividends | 0.00 | 0.47 | - |
Returns for 1 year | 20.85 | 15.96 | 131% |
Returns for 3 years | 64.74 | 55.11 | 117% |
Returns for 5 years | 41.55 | 38.56 | 108% |
Returns for 10 years | 212.22 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MSMR | 32.61 | 0.14 | +0.43% |
McElhenny Sheffield Managed Risk ETF | |||
JPSV | 60.01 | 0.24 | +0.39% |
JPMorgan Active Small Cap Value ETF | |||
BME | 36.65 | N/A | N/A |
Blackrock Health Sciences Trust | |||
FARX | 25.84 | N/A | N/A |
Frontier Asset Absolute Return ETF | |||
NVDL | 89.01 | -1.54 | -1.70% |
GraniteShares 2x Long NVDA Daily ETF |